Project Grant R61DA062333
Award Date 4/1/26
Completion Date 3/31/28
Dollars Obligated $557K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $399,600 to Brigham & Women's Hospital Inc. under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 15, 2025, through a Mentored Research Scientist Development Award (K01) mechanism. The award supports a five-year career development and research program under the principal investigator, Dr. Jason Brian Gibbons, Assistant Professor at the University of Colorado Anschutz Medical Campus. The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH) effective March 1, 2026 through February 28, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year award supports research to evaluate the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The research will deliver two primary...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $709,085 to the University of Colorado-Denver for an implementation research trial commencing April 1, 2026, and concluding January 31, 2031. This project delivers implementation facilitation services and clinical intervention support designed to expand in-hospital opioid treatment program (OTP) intakes for hospitalized patients with opioid...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Biomotivate LLC a $613,744 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support emotional regulation and resilience in individuals with opioid use disorders (OUDs). The platform combines generative artificial intelligence, predictive analytics,...
- Federal Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. This mentored research career development award supports a mixed-methods study examining the impact of Massachusetts's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program—a statewide Medicaid initiative launched in 2022...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital a $598,000 Project Grant on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop advanced machine learning methodologies for detecting emerging drug supply trends and overdose patterns. The research will leverage the National Forensic Laboratory Information System (NFLIS-Drug) data, which contains detailed drug composition reports from...
- Federal Project Grant Summary Berkshire Biomedical Corporation received a $326,410 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 1, 2025 through May 31, 2027. The award funds COPA (A Clinical Program to Evaluate Benefits of a Hand-Held, Automated, Personalized Oral Liquid Dispensing System), a clinical research initiative designed to evaluate a hand-held automated dispensing device for...
- Federal Grant Award Summary Boston Interactome LLC received a $398,137 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 1, 2025 through April 30, 2027. The award supports the development of high-precision epigenetic therapeutics for opioid use disorder (OUD) by targeting protein-protein interactions (PPI) within epigenetic protein complexes. The research adapts a novel molecular approach previously...
- Federal Project Grant Award Summary The University of Pennsylvania received a $2.13 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded May 15, 2025, with completion targeted for February 28, 2030. This research initiative addresses the critical public health challenge of opioid overdose mortality by advancing evidence-based naloxone (an overdose reversal medication) implementation in public libraries...
- Federal Project Grant Award Summary Rescue Biomedical, LLC received a $799,430 Phase I Small Business Innovation Research (SBIR) Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period of August 1, 2025 through July 31, 2026. The company is developing the Automatic Detection Device (AD2), a user-centric wearable overdose detection module designed as the initial commercialization phase of its broader Automatic...